BIO — 2026 — San Diego Convention Center, San Diego, USA
Biocom is excited to announce the upcoming Noven Pharmaceuticals Partner Day on Wednesday, June 10. To explore potential collaboration opportunities through 1:1 meetings with Noven Pharmaceuticals leadership, please submit an application by Monday, May 25.Representatives from Nov
Presentation data updated Jun 6, 2026, 5:32 AM UTC
- Media coverage 20/20
- Speaker quality 20/20
- Pipeline relevance 1/20
- Historical influence 20/20
- Company participation 10/20
Key Takeaways
Key Themes
Key Companies
Key Drugs
Key Markets
Key Opportunities
Key Data to Watch
Phase III Lp(a)HORIZON study of pelacarsen: top-line results
Phase III data readout for a key trial in oncology (partnered with Summit Therapeutics)
Phase III data readouts for key studies in oncology (H1 and H2 2026)
Initial readouts from ongoing trials in immunoglobulin A nephropathy (IgAN) and primary membranous nephropathy
Business update and 2026 financial results with pipeline progress